Incidence and progression of hand osteoarthritis in a large community-based cohort: the Johnston County Osteoarthritis Project

Incidence and progression of hand osteoarthritis in a large community-based cohort: the Johnston County Osteoarthritis Project

Journal Pre-proof Incidence and Progression of Hand Osteoarthritis in a Large Community-Based Cohort: The Johnston County Osteoarthritis Project E. Am...

389KB Sizes 0 Downloads 34 Views

Journal Pre-proof Incidence and Progression of Hand Osteoarthritis in a Large Community-Based Cohort: The Johnston County Osteoarthritis Project E. Amanda Snyder, MD, Carolina Alvarez, MS, Yvonne M. Golightly, PT PhD, Jordan B. Renner, MD, Joanne M. Jordan, MD MPH, Amanda E. Nelson, MD MSCR PII:

S1063-4584(20)30094-7

DOI:

https://doi.org/10.1016/j.joca.2020.02.028

Reference:

YJOCA 4604

To appear in:

Osteoarthritis and Cartilage

Received Date: 24 September 2019 Revised Date:

23 December 2019

Accepted Date: 3 February 2020

Please cite this article as: Snyder EA, Alvarez C, Golightly YM, Renner JB, Jordan JM, Nelson AE, Incidence and Progression of Hand Osteoarthritis in a Large Community-Based Cohort: The Johnston County Osteoarthritis Project, Osteoarthritis and Cartilage, https://doi.org/10.1016/j.joca.2020.02.028. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

1

Incidence and Progression of Hand Osteoarthritis in a Large Community-Based Cohort:

2

The Johnston County Osteoarthritis Project

3 4

E. Amanda Snyder MD1,2, Carolina Alvarez MS1, Yvonne M. Golightly PT PhD1,3, Jordan B.

5

Renner MD1,4, Joanne M. Jordan MD MPH1,2,3, Amanda E. Nelson MD MSCR1,2

6

1. Thurston Arthritis Research Center, University of North Carolina at Chapel Hill

7

2. Department of Medicine, University of North Carolina at Chapel Hill

8

3. Department of Epidemiology, Gillings School of Global Public Health, University of North

9

Carolina at Chapel Hill

10

4. Department of Radiology, University of North Carolina at Chapel Hill

11 12

Corresponding author: Amanda E. Nelson MD MSCR, University of North Carolina at Chapel

13

Hill, 3300 Doc J. Thurston Building, Campus Box 7280, Chapel Hill, NC 27599-7280

14 15

Emails - EAS: [email protected]; CA: [email protected]; YMG:

16

[email protected]; JBR: [email protected]; JMJ:

17

[email protected]; AEN: [email protected]

1

18

Objective: To describe the incidence and progression of radiographic and symptomatic hand

19

osteoarthritis (rHOA and sxHOA) in a large community-based cohort.

20

Design: Data were from the Johnston County OA Project (1999-2015, 12 ±1.2 years follow-up,

21

age 45+). Participants had bilateral hand radiographs each visit, read for Kellgren-Lawrence

22

grade (KLG) at 30 joints. We defined rHOA as KLG ≥2 in ≥1 joint. SxHOA was defined in a

23

hand/joint with rHOA and self-reported symptoms or tenderness on exam. Incidence was

24

assessed in those without, while progression was assessed in those with, baseline rHOA.

25

Proportions or medians are reported; differences by sex and race were assessed using models

26

appropriate for dichotomous or continuous definitions, additionally adjusted for age, education,

27

BMI, and weight change.

28

Results: Of 800 participants (68% women, 32% African American, mean age 60 years), 327

29

had baseline rHOA and were older, more often white and female, than those without rHOA

30

(n=473). The incidence of HOA was high, for rHOA (60%) and for sxHOA (13%). Women were

31

more likely than men to have incident HOA, particularly for DIP rOA (aOR 1.60 95% CI [1.03,

32

2.49]) and sxHOA (aOR 2.98 [1.50, 5.91]). Progressive HOA was more similar by sex, although

33

thumb base rOA progressed more frequently in women than in men (aOR 2.56 [1.44, 4.55]).

34

Particularly HOA incidence, but also progression, was more frequent among whites compared

35

with African Americans.

36

Conclusion: This study provides much needed information about the natural history of HOA, a

37

common and frequently debilitating condition, in the general population.

38 39

Keywords: Hand osteoarthritis, radiographs, epidemiology

40 41

Running title: Incidence and Progression of Hand OA

42 43 2

44

The presentation of osteoarthritis (OA) varies immensely – affecting adults of all ages and

45

involving different joints throughout the body.1 Although hand osteoarthritis (HOA) is

46

exceedingly common and will affect 4 in 10 people by age 852, this joint site is understudied in

47

comparison to other sites, like the knee. HOA is a heterogeneous disease that presents as

48

bony enlargement and deformities of various joints in the hand.3 Patients may experience pain,

49

stiffness and decreased mobility, which can result in decreased grip strength and functionality of

50

the hand.4 As such, HOA can lead to significant disability and increased healthcare utilization.5

51 52

To date, studies of HOA are limited – particularly with regard to incidence and progression of

53

disease in longitudinal cohorts. Review of the literature reveals that prevalence estimates of

54

HOA in adults vary depending on the population studied and definitions used to define the

55

disease. HOA can be defined radiographically and/or symptomatically, and such definitions can

56

affect frequency estimates.6 For example, the Framingham OA Study estimated the frequency

57

of symptomatic HOA as 13% in men and 26% in women > 70 years of age, but only includes

58

white individuals.7 As the US population is aging, these data suggest more people will be

59

affected by HOA in the future highlighting the need for better understanding of the natural

60

history of this common condition, including differences by sex and race.

61 62

The purpose of this study was to utilize recent longitudinal data to describe the incidence and

63

progression of radiographic and symptomatic HOA (rHOA and sxHOA, respectively) in a large

64

community-based cohort of African American and white men and women.

65 66

Participants and Methods

67

Data were obtained from adult participants (age ≥ 45 years) in the Johnston County

68

Osteoarthritis Project (JoCo OA), an ongoing community-based prospective observational

69

cohort study monitoring the occurrence and natural history of OA in Johnston County, North 3

70

Carolina.8 JoCo OA enrolled non-institutionalized white and African American adults age 45

71

and older who resided in 6 townships in the county in a population-based manner (without

72

regard for symptoms or diagnosis). All participants provide informed consent, answer

73

standardized questionnaires and undergo an examination with trained staff, in addition to

74

radiography of multiple joint sites. This analysis included all participants at the third JoCo OA

75

follow up (n=909, collected 2013-15), and included data from all prior time points with hand data

76

for these individuals (first follow-up: 1999-2003 or cohort enrichment: 2003-4, and second

77

[combined] follow up: 2006-10). After exclusion of 109 participants due to missing radiographs

78

over time (n=84) or missing any of the 30 specific joint scores over time (n=25), 800 participants

79

were included in the complete case analysis (Figure 1).

80

Sex, race, and age were from self-report at baseline. Educational attainment at baseline was

81

categorized as completing less than a high school education vs at least a high school education.

82

Body mass index (BMI) at baseline was computed from measured standing height (cm) and

83

weight (kg) during the research clinic visit. Weight gain from baseline (T1) to second follow-up

84

(T3) was defined as more than a 5% increase in BMI.

85

All participants had posteroanterior radiographs of the bilateral hands at each visit, read

86

together in known time order9, 10 by an experienced musculoskeletal radiologist (JBR) using the

87

Kellgren-Lawrence grading (KLG) system11 for all 30 joints (bilateral distal interphalangeal [DIP]

88

2-5; proximal interphalangeal [PIP] 2-5; metacarpophalangeal [MCP] 1-5; interphalangeal [IP]

89

and carpometacarpal [CMC] of the thumb). The radiologist has previously demonstrated high

90

reliability (kappa >0.7), detailed by joint in a prior paper.2 Erosive OA was not systematically

91

assessed in this study, but noted only as a comment and appeared to be relatively uncommon

92

in this sample (9 participants). Therefore, erosive OA was not analyzed separately, although

93

these participants were included in the analyses for other outcomes.

94

4

95

There are many ways to define rHOA.12 For these analyses, we considered several definitions.

96

First, rHOA overall was defined as a KLG of 2 or more in at least 1 of the 30 hand joints.

97

Additionally, rOA by joint group (DIP, PIP, thumb IP, MCP, or CMC, involving at least one joint

98

in the group) and rHOA affecting 2 or more joints was assessed. We also considered the

99

number of joints affected by KLG of 2 or more and the sum score of KLG (0-4 at each joint)

100

across all 30 joints (range 0-120). SxHOA was defined as the presence of symptoms defined in

101

one of two ways with rOA in the same hand or specific joint site. First, self-reported pain, aching

102

or stiffness in the entire hand was assessed using the answer to “On most days, do you have

103

pain, aching, or stiffness in your hands” at baseline, which was modified at follow up to: “On

104

most days of any one month in the last twelve months, did you have pain, aching, or stiffness in

105

your hands?” at follow up, both with indicators for right or left hand. Second, tenderness to

106

palpation at each of the 30 hand joints during the research exam was assessed (previously

107

shown to be reliable, with agreement >0.9 for two trained readers1). We additionally considered

108

the number of joints with sxHOA.

109 110

Two groups were defined: those with baseline rHOA (KLG of 2 or more in at least 1 of the 30

111

hand joints) and those without. Among those without baseline rHOA, we defined incident rHOA

112

as newly meeting the above criteria in a hand or joint previously without rOA. Among those with

113

baseline rHOA, progression was defined as an additional joint involved, either overall or in a

114

given joint group for both rHOA and sxHOA. We again considered the overall number of rHOA

115

joints and sxHOA joints as well as the total sum KLG for progression.

116 117

Incidence and progression were assessed over an average of 12 years involving a baseline

118

(either first follow up: 1999-2004 or cohort enrichment: 2003-4) and two combined follow-up

119

time-points (2006-2010 and 2013-2015). Descriptive statistics were shown as proportions for

120

dichotomous variables and medians (interquartile range) for continuous variables. 5

121

Most incidence and progression differences between sex and race were assessed by modeling

122

dichotomous definitions with logistic regression and producing adjusted odds ratios (aOR) and

123

95% confidence intervals (95% CI) describing associations. For continuous definitions

124

(consisting of skewed count distributions) either zero-inflated negative binomial, scaled negative

125

binomial or scaled regression models were used to produce adjusted incidence density ratios

126

(aIDR) or adjusted betas (β) and 95% CI describing associations. Models were adjusted for

127

age, sex, race, education, BMI, weight gain of 5% or more, and HOA baseline values (for

128

progression only).

129 130

Results

131

Of the 800 included participants (Figure 1), 68% were women and 32% were African American

132

(Table 1). The mean age of the sample was 59.6 (standard deviation ± 7.5) years, and the

133

mean body mass index (BMI) was 31.0 ± 6.4 kg/m2. Those with baseline rHOA (n=327, 41% of

134

the sample) tended to be older (63 ± 7 vs 57 ± 7 years) and were more often white (80% vs

135

61%) and women (72% vs 65%) than those without baseline rHOA (n=473, 59% of the sample).

136

Socioeconomic status as represented by education level did not differ between groups, nor did

137

the proportion experiencing weight gain over the course of the study (Table 1).

138 139 140

Incident HOA The frequencies of incident rHOA (≥1 or ≥2 joints), DIP rOA, PIP rOA, thumb IP rOA,

141

and thumb base rOA were slightly higher among women, while men were more likely to have

142

incident MCP rOA (Table 2). In adjusted models, women had statistically significantly greater

143

odds of DIP rOA (aOR 1.60, 95% CI [1.03, 2.49]) and had, on average, 1.33 times the number

144

of rHOA affected joints compared with men.

145 146

Incident sxHOA was significantly more likely in women (16% vs 7%), who also had more joints with sxHOA (but not rHOA) compared with men. Both differences were statistically 6

147

significant in adjusted models, where women had nearly 3 times the odds of developing sxHOA

148

and had 4.7 times more joints affected with sxHOA than men. The overall KLG sum score

149

across all joints was similar by sex.

150

All definitions of rHOA and sxHOA were more common in white compared with African

151

American participants, particularly for rHOA (≥1 joint), DIP OA, and thumb base OA (Table 2),

152

all of which were at least twice as likely among whites in adjusted models. SxHOA was more

153

than twice as frequent in white compared to African American participants (17% vs 6%), with an

154

adjusted odds ratio over 4. The number of joints affected by rHOA or sxHOA, and the overall

155

KLG sum, were also higher in white participants, although the adjusted IDR was only significant

156

for number of joints with rHOA (aIDR 2.00 [1.54, 2.61]).

157

Progression of HOA

158

Progressive rHOA was seen at similar frequencies between men and women, except for

159

MCP rOA, which more commonly progressed in men (58% vs 39%), and thumb base rOA,

160

which progressed more often in women (61% vs 41%, Table 3). Only thumb base OA was

161

statistically significant in adjusted models, where women had 2.5 times the odds of progression

162

compared with men. Progressive rHOA and sxHOA were slightly but not statistically significantly

163

more common in women compared with men. Women also had more joints involved with rHOA

164

and sxHOA over time, although this was not significant in adjusted models.

165

All measures of HOA progression were higher among whites compared with African

166

Americans, although most were modestly so (Table 3). Thumb base rOA progression was

167

significantly more frequent among white compared with African American participants (61% vs

168

34%), as was sxHOA progression (32% vs 25%, respectively); both remained significant in

169

adjusted models. Additionally, the number of joints affected and the change in number of joints

170

involved were slightly higher among whites compared with African Americans, although not

171

statistically significant after adjustment.

172 7

173

Discussion

174

HOA remains understudied in comparison to other common sites of OA, like the hip and knee.

175

While several studies have described the prevalence of hand OA in various populations, there

176

have been surprisingly few analyses of the incidence and progression of OA in longitudinal,

177

community-based cohorts. An understanding of the natural history of this common and often

178

debilitating condition is essential to informing further study, including the development of new

179

interventions. In this longitudinal, community-based cohort including African American and white

180

men and women, we found high frequencies of new disease over an average of 12 years,

181

particularly for rHOA (60%) but also for sxHOA (13%). For most joint sites, compared with men,

182

women were somewhat more likely to have incident HOA, although the opposite was true at the

183

MCP. The differences by race were more apparent, with white participants experiencing much

184

higher frequencies of incident HOA by most definitions. HOA progression was similarly

185

common, with rHOA progression occurring in the majority of the sample and sxHOA in about

186

two out of every five (41%). Differences by sex were similar for progression and for incidence,

187

while differences by race were somewhat less pronounced. Of note, more than 1/4 of the

188

sample, regardless of subgroup, had progressive sxHOA with at least one additional joint

189

involved over the follow-up period (28% of African Americans, 35% of men, 43% of whites and

190

44% of women), emphasizing the burden of this condition.

191 192

There are a few large cohort studies to which we can compare our findings. Haugen, et al13,

193

using data from the Framingham OA Study (FOA, collected 1992-5 and 2002-5), reported 9-

194

year cumulative incidence for similar definitions of HOA that were overall lower than those

195

reported here (e.g., rHOA approximately 34%, PIP 5%, although thumb base OA was

196

comparable at 17% in men and 21% in women). However, the pattern of sex differences was

197

similar between the two studies. For progression over 9 years, the overall frequencies were

198

fairly similar to the current report (e.g., rHOA progression in >90%), although DIP progression 8

199

was slightly lower among women in the JoCo OA than in the FOA (74% vs. 78%, respectively)

200

but higher in men, (72% in JoCo OA vs. 59% in FOA). Additionally, PIP and MCP progression

201

were more common in JoCo OA compared with FOA. Thumb base OA progression was more

202

frequent in FOA (<50% in JoCo OA, >60% in FOA), again with similar patterns by sex. Among

203

individuals with hand pain but without baseline rHOA in the Clinical Assessment Studies of the

204

Hand study14, the KLG sum (for 20 joints; no MCP) increased by 9 in women and 7 in men over

205

7 years, not dissimilar to the increase of 12 and 11 in the current analysis over 12 years

206

(although the latter sum was for 30 joints). In the Genetics, Arthrosis and Progression study15, a

207

family study of multiple joint OA, the pattern of progression was similar to the present study, with

208

HOA progression most frequent in the DIPs, then CMC, PIP/IP and MCPs. In a few smaller

209

studies in more specific populations, progression has been shown to be a common occurrence,

210

although often modest in severity16-18. Of course, these are very different populations and

211

utilized somewhat different methodologies so are not directly comparable. The fact that there

212

are not more studies, and that there are none in diverse populations (all of the above studies

213

were among whites), highlights the need for additional work in this area.

214 215

We have previously reported on the cross-sectional frequency of multiple joint OA phenotypes,

216

including HOA, by race and sex in the JoCo OA.19, 20 We found that, compared to whites, African

217

Americans were less likely to have phenotypes that included rHOA20 or sxHOA19, although they

218

were more likely to have phenotypes involving one or more large joints. Additionally, the lifetime

219

risk of sxHOA was lower among African Americans compared with whites in this cohort (29.2%

220

vs. 41.4%).2 A large cross-sectional study in young (age 42-53) African American and white

221

women nearly two decades ago found a similar prevalence of hand OA by race, although MCP

222

OA was more common among African American (12%) compared with white (3%) women;

223

African American women were also more likely to have both hand and knee OA (8% vs 2% of

224

white women)21. Unfortunately, we are not aware of any other community-based studies 9

225

including African Americans that are available for comparison, and the mechanisms behind

226

these differences are not known.

227 228

Limitations of this work include small numbers in some categories which precluded more

229

detailed modeling. As in most large cohorts, we have relatively infrequent assessments of

230

symptoms, and are not able to model detailed fluctuations in symptoms over time. We focused

231

on incidence and progression and did not separately analyze improvements in symptoms over

232

time. However, the strengths, including the large overall sample size, the unique biracial cohort

233

including both men and women, and the community-based nature of the cohort, make this an

234

important contribution to the HOA literature.

235 236

In this large, longitudinal, community-based cohort inclusive of African American and white men

237

and women, we found overall high frequencies of both incidence and progression of HOA over

238

an average of 12 years of follow up. Although common across the board, the frequencies of

239

incident and progressive HOA by a variety of definitions were generally higher in women

240

compared with men and among whites compared with African Americans; differences were

241

overall more marked for definitions of incidence than for progression. Additional studies are

242

needed to understand potential mechanisms for the identified differences (e.g., occupational,

243

genetic, nutritional, biomechanical, or other factors).

244 245

10

246

Acknowledgments: We would like to thank the staff and participants in the Johnston County

247

Osteoarthritis Project, without whom this work would not be possible.

248

Author contributions:

249

Conception and design: EAS, CA, YMG, AEN

250

Acquisition of data: JBR, JMJ

251

Analysis and interpretation of data: EAS, CA, YMG, JBR, JMJ, AEN

252

Drafting the article or revising it critically for important intellectual content: EAS, CA, YMG, JBR,

253

JMJ, AEN

254

Final approval of the version to be submitted: EAS, CA, YMG, JBR, JMJ, AEN

255

Dr. Nelson takes responsibility for the integrity of the work as a whole.

256

Role of the funding source:

257

This work is funded in part by: CDC U01 DP006266 and DP003206, NIH/NIAMS P60

258

AR049465 and AR064166. The funding agencies had no role in the design, analysis, or

259

interpretation of data, nor in the writing of the manuscript or the decision to submit it for

260

publication.

261

Competing interest statement:

262

None of the authors has any competing interests in relation to this work.

263 264 265 266 267 268

Figure Legend Figure 1. Flow chart of participant inclusion in the current analysis

11

269 270 271

References 1.

Gullo TR, Golightly YM, Cleveland RJ, Renner JB, Callahan LF, Jordan JM, et al.

272

Defining multiple joint osteoarthritis, its frequency and impact in a community-based

273

cohort. Semin Arthritis Rheum 2019;48:950-957. doi:10.1016/j.semarthrit.2018.10.001.

274

2.

Qin J, Barbour KE, Murphy LB, Nelson AE, Schwartz TA, Helmick CG, et al. Lifetime

275

Risk of Symptomatic Hand Osteoarthritis: The Johnston County Osteoarthritis Project.

276

Arthritis Rheumatol 2017;69:1204-1212. doi:10.1002/art.40097.

277

3.

Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR

278

evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a

279

task force of ESCISIT. Ann Rheum Dis 2009;68:8-17. doi:10.1136/ard.2007.084772.

280

4.

Michon M, Maheu E, Berenbaum F. Assessing health-related quality of life in hand

281

osteoarthritis: a literature review. Ann Rheum Dis 2011;70:921-928.

282

doi:10.1136/ard.2010.131151.

283

5.

Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand,

284

hip, and knee osteoarthritis among patients in a health maintenance organization.

285

Arthritis Rheum 1995;38:1134-1141.

286

6.

Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of

287

osteoarthritis definition on prevalence and incidence estimates: a systematic review.

288

Osteoarthritis Cartilage 2011;19:1270-1285. doi:10.1016/j.joca.2011.08.009.

289

7.

Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of

290

symptomatic hand osteoarthritis and its impact on functional status among the elderly:

291

The Framingham Study. Am J Epidemiol 2002;156:1021-1027.

292

8.

Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, et al. Prevalence

293

of knee symptoms and radiographic and symptomatic knee osteoarthritis in African

294

Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol

295

2007;34:172-180. 12

296

9.

Felson DT, Nevitt MC. Blinding images to sequence in osteoarthritis: evidence from

297

other diseases. Osteoarthritis Cartilage 2009;17:281-283.

298

doi:10.1016/j.joca.2008.09.008.

299

10.

Gensburger D, Roux JP, Arlot M, Sornay-Rendu E, Ravaud P, Chapurlat R. Influence of

300

blinding sequence of radiographs on the reproducibility and sensitivity to change of joint

301

space width measurement in knee osteoarthritis. Arthritis Care Res (Hoboken)

302

2010;62:1699-1705. doi:10.1002/acr.20311.

303

11.

304 305

Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502. doi:10.1136/ard.16.4.494.

12.

Marshall M, Dziedzic KS, van der Windt DA, Hay EM. A systematic search and narrative

306

review of radiographic definitions of hand osteoarthritis in population-based studies.

307

Osteoarthritis Cartilage 2008;16:219-226. doi:10.1016/j.joca.2007.06.004.

308

13.

Haugen IK, Englund M, Aliabadi P, Niu J, Clancy M, Kvien TK, et al. Prevalence,

309

incidence and progression of hand osteoarthritis in the general population: the

310

Framingham Osteoarthritis Study. Ann Rheum Dis 2011;70:1581-1586.

311

doi:10.1136/ard.2011.150078.

312

14.

Marshall M, Peat G, Nicholls E, Myers HL, Mamas MA, van der Windt DA. Metabolic risk

313

factors and the incidence and progression of radiographic hand osteoarthritis: a

314

population-based cohort study. Scand J Rheumatol 2019;48:52-63.

315

doi:10.1080/03009742.2018.1459831.

316

15.

Bijsterbosch J, Meulenbelt I, Watt I, Rosendaal FR, Huizinga TW, Kloppenburg M.

317

Clustering of hand osteoarthritis progression and its relationship to progression of

318

osteoarthritis at the knee. Ann Rheum Dis 2014;73:567-572. doi:10.1136/annrheumdis-

319

2012-202461.

13

320

16.

Paradowski PT, Lohmander LS, Englund M. Natural history of radiographic features of

321

hand osteoarthritis over 10 years. Osteoarthritis Cartilage 2010;18:917-922.

322

doi:10.1016/j.joca.2010.04.008.

323

17.

Balblanc JC, Mathieu P, Mathieu L, Tron AM, Conrozier T, Piperno M, et al. Progression

324

of digital osteoarthritis: a sequential scintigraphic and radiographic study. Osteoarthritis

325

Cartilage 1995;3:181-186. doi:10.1016/s1063-4584(05)80052-4.

326

18.

Harris PA, Hart DJ, Dacre JE, Huskisson EC, Spector TD. The progression of

327

radiological hand osteoarthritis over ten years: a clinical follow-up study. Osteoarthritis

328

Cartilage 1994;2:247-252. doi:10.1016/s1063-4584(05)80076-7.

329

19.

Nelson AE, Golightly YM, Renner JB, Schwartz TA, Kraus VB, Helmick CG, et al. Brief

330

report: differences in multijoint symptomatic osteoarthritis phenotypes by race and sex:

331

the Johnston County Osteoarthritis Project. Arthritis Rheum 2013;65:373-377.

332

doi:10.1002/art.37775.

333

20.

Nelson AE, Renner JB, Schwartz TA, Kraus VB, Helmick CG, Jordan JM. Differences in

334

multijoint radiographic osteoarthritis phenotypes among African Americans and

335

Caucasians: The Johnston County Osteoarthritis project. Arthritis Rheum 2011;63:3843-

336

3852. doi:10.1002/art.30610.

337

21.

Sowers M, Lachance L, Hochberg M, Jamadar D. Radiographically defined osteoarthritis

338

of the hand and knee in young and middle-aged African American and Caucasian

339

women. Osteoarthritis Cartilage 2000;8:69-77. doi:10.1053/joca.1999.0273.

340 341

14

Table 1. Descriptive characteristics of the sample overall and by baseline hand OA status Sample

Overall (n=800)

No baseline hand OA

Baseline hand OA

(n=473)

(n=327)

mean (SD) or %

mean (SD) or %

mean (SD) or %

Age, years

59.6 (7.5)

57.3 (6.6)

63.1 (7.4)

Female, %

68.0

65.3

71.9

African American, %

31.5

39.5

19.9

<12 years education, %

13.8

13.8

13.8

31.0 (6.4)

31.6 (6.7)

30.2 (5.9)

32.6

33.4

31.5

Characteristics

Baseline body mass index, kg/m2 >5% weight gain from baseline to follow up, %

15

Table 2. Proportions by hand OA incidence definition over ~ 12 (±1.2) year follow-up for those without baseline hand OA, by sex or race Hand OA incidence definition

Overall

Women

Men

(n=473)

(n=309)

(n=164)

Women vs Men*

White

African

(n=286)

American

White vs AA*

(n=187) % or median

effect (95% CI)

% or median

(interquartile

(interquartile

range: Q1-Q3)

range: Q1-Q3)

effect (95% CI)

59.4%

60.5%

57.3%

1.26 (0.84, 1.90)

65.0%

50.8%

2.26 (1.49, 3.43)

– 5 ) OA

32.1%

34.0%

28.7%

1.60 (1.03, 2.49)

40.2%

19.8%

3.16 (1.97, 5.07)

PIP (2nd – 5th) OA

20.1%

21.4%

17.7%

1.24 (0.82, 1.87)

22.7%

16.0%

1.17 (0.77, 1.77)

Thumb IP OA

24.5%

24.9%

23.8%

1.02 (0.64, 1.61)

23.1%

26.7%

0.87 (0.55, 1.37)

MCP (1 – 5 ) OA

13.5%

11.7%

17.1%

0.59 (0.34, 1.04)

13.6%

13.4%

1.08 (0.60, 1.95)

Thumb base OA

20.7%

22.3%

17.7%

1.59 (0.96, 2.64)

24.1%

15.5%

2.11 (1.24, 3.58)

Radiographic HOA (≥2 joint(s))

31.7%

33.0%

29.3%

1.18 (0.78, 1.79)

35.3%

26.2%

1.60 (1.05, 2.45)

Symptomatic HOA (≥1 joint(s))

12.9%

15.9%

7.3%

2.98 (1.50, 5.91)

17.1%

6.4%

4.29 (2.08, 8.86)

Number of radiographic HOA

1 (0-3)

1 (0-3)

1 (0-2)

1.33 (1.03, 1.72)

1

1 (0-3)

1 (0-2)

2.00 (1.54, 2.61)

1

0 (0-0)

0 (0-0)

0 (0-0)

4.74 (2.08, 10.8)

1

0 (0-0)

0 (0-0)

1.69 (0.41, 7.06)

1

Max=93

Max=9

Max=2

Max=9

Max=3

At T3:

At T3:

At T3:

At T3:

At T3:

Radiographic HOA (≥1 joint(s)) DIP (2

nd

st

th

th

joints Number of symptomatic HOA joints Total sum KL score (30 joints)

0.99 (0.95, 1.03)2

1.00 (0.96, 1.04)2

16

11 (7-19)

12 (8-19)

11 (7-18)

12 (8-20)

11 (7-16)

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

7 (4-12)

7 (4-12)

8 (4-11)

8 (5-14)

6 (3-9)

Distal interphalangeal joint (DIP), Hand osteoarthritis (HOA), Interphalangeal joint (IP), Kellgren-Lawrence grade (KLG), Metacarpophalangeal joint (MCP), Osteoarthritis (OA), Proximal interphalangeal joint (PIP); ∆=change from T1 to T3 (baseline to follow up) Effects shown are adjusted for baseline: age, sex, race, education, BMI, and weight gain—additionally adjusted for HOA baseline values for total sum KL score. *Logit models for categorical definitions producing adjusted odds ratios (aOR) and 1 zero inflated negative binomial models for continuous definitions producing adjusted incidence density ratios (aIDR) and 2 scaled negative binomial model for continuous definitions producing adjusted incidence density ratios (aIDR)

17

Table 3. Proportion by hand OA progression definition over ~ 12 (±1.2) year follow-up for those with baseline hand OA, by sex or race Hand OA progression definition

Overall

Women

Men

(n=327)

(n=235)

(n=92)

Women vs Men*

White

African

(n=262)

American

White vs AA*

(n=65) % or median

effect (95% CI)

(interquartile

effect (95% CI)

(interquartile

range: Q1-Q3) Radiographic HOA

% or median

range: Q1-Q3)

94.2%

94.0%

94.6%

0.70 (0.22, 2.22)

95.4%

89.2%

1.15 (0.38, 3.45)

n=306

n=218

n=88

1.26 (0.67, 2.37)

n=242

n=64

1.39 (0.70, 2.76)

77.8%

79.4%

73.9%

81.0%

65.6%

n=318

n=228

n=90

n=254

n=64

63.5%

66.2%

56.7%

65.0%

57.8%

n=286

n=205

n=81

n=228

n=58

56.3%

54.2%

61.7%

57.9%

50.0%

MCP (1 – 5 ) OA

44.0%

38.7%

57.6%

0.61 (0.36, 1.05)

44.7%

41.5%

0.96 (0.52, 1.77)

Thumb base OA

n=274

n=193

n=81

2.56 (1.44, 4.55)

n=215

n=59

3.39 (1.74, 6.60)

54.7%

60.6%

40.7%

60.5%

33.9%

80.4%

81.3%

78.3%

82.4%

72.3%

(additional in ≥1 joint(s)) nd

th

DIP (2 – 5 ) OA

nd

th

PIP (2 – 5 ) OA

Thumb IP OA

st

th

Radiographic HOA

1.38 (0.80, 2.37)

0.80 (0.46, 1.37)

1.11 (0.59, 2.10)

0.94 (0.51, 1.76)

1.30 (0.71, 2.40)

1.08 (0.53, 2.18)

18

(additional ≥2 joint(s))

Symptomatic HOA

31.0%

31.9%

28.6%

1.25 (0.72, 2.16)

32.4%

25.0%

At T3:

At T3:

At T3:

1

At T3:

At T3:

9 (4-14)

9 (5-15)

8 (4-12)

10 (5-15)

6 (3-10)

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

5 (2-8)

6 (3-9)

5 (2-7)

6 (3-8)

4 (2-8)

Number of symptomatic

At T3:

At T3:

At T3:

At T3:

At T3:

HOA joints

0 (0-1)

0 (0-2)

0 (0-1)

0 (0-1)

0 (0-0)

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

0 (0-1)

0 (0-1)

0 (0-0)

0 (0-1)

0 (0-0)

At T3:

At T3:

At T3:

At T3:

At T3:

34 (21-45)

35 (22-47)

32.5 (19-42)

35 (23-47)

27 (17-37)

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

∆ T3-T1:

16 (9-22)

16 (10-23)

14.5 (8.5-20.5)

17 (10-22)

13 (8-18)

1.96 (1.01, 3.83)

(additional ≥1 joint(s)) Number of radiographic HOA joints

Total sum KL score (30 joints)

1.17 (0.99, 1.39)

0.23 (-0.34, 0.81)

1.09 (0.97, 1.24)

2

1

1.12 (0.92, 1.36)

1

0.46 (-0.21, 1.12)

1.09 (0.94, 1.26)

2

1

Distal interphalangeal joint (DIP), Hand osteoarthritis (HOA), Interphalangeal joint (IP), Kellgren-Lawrence grade (KLG), Metacarpophalangeal joint (MCP), Osteoarthritis (OA), Proximal interphalangeal joint (PIP); ∆=change from T1 to T3 (baseline to follow up) Effects shown are adjusted for baseline: age, sex, race, education, BMI, weight gain, and HOA baseline values. *Logit models for categorical definitions producing adjusted odds ratios (aOR) and 1 scaled negative binomial model for continuous definitions producing adjusted incidence density ratios (aIDR) and 2 scaled regression models for the number of symptomatic HOA joints producing adjusted betas.

19

STROBE Statement—Checklist of items that should be included in reports of cohort studies

Title and abstract

Item No 1

Line or page # in ms Recommendation (a) Indicate the study’s design with a commonly used term in the

Line 1

title or the abstract (b) Provide in the abstract an informative and balanced summary of

Page 2

what was done and what was found Introduction Background/rationale

2

Explain the scientific background and rationale for the

Page 3

investigation being reported Objectives

3

State specific objectives, including any prespecified hypotheses

Methods Study design

4

Present key elements of study design early in the paper

Setting

5

Describe the setting, locations, and relevant dates, including

Lines 68-70 Page 3-5 Lines 73-82

periods of recruitment, exposure, follow-up, and data collection Participants

6

(a) Give the eligibility criteria, and the sources and methods of

Lines 73-82 and 109-

selection of participants. Describe methods of follow-up

115

(b) For matched studies, give matching criteria and number of

n/a

exposed and unexposed Variables

7

Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if

Lines 84-107

applicable Data sources/

8*

measurement

For each variable of interest, give sources of data and details of

Lines 84-115

methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group

Bias

9

Describe any efforts to address potential sources of bias

Study size

10

Explain how the study size was arrived at

Lines 78-82

Quantitative

11

Explain how quantitative variables were handled in the analyses. If

Lines 92-107

variables Statistical methods

n/a (descriptive)

applicable, describe which groupings were chosen and why 12

(a) Describe all statistical methods, including those used to control

Lines 109-115

for confounding (b) Describe any methods used to examine subgroups and

Lines 109-115

interactions (c) Explain how missing data were addressed (d) If applicable, explain how loss to follow-up was addressed (e) Describe any sensitivity analyses Results Participants

13*

(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed

Line 82 Line 77-82 n/a Lines 77-82 and 118120

eligible, included in the study, completing follow-up, and analysed (b) Give reasons for non-participation at each stage (c) Consider use of a flow diagram

Lines 77-82 Unable due to journal constraints

Descriptive data

14*

(a) Give characteristics of study participants (eg demographic,

Lines 118-122

clinical, social) and information on exposures and potential confounders (b) Indicate number of participants with missing data for each variable of interest

Complete case analysis, line 82

1

(c) Summarise follow-up time (eg, average and total amount)

Lines 109-111 and

Report numbers of outcome events or summary measures over time

Lines 120-122 and

Tables 1&2 Outcome data

15*

Tables 1&2 Main results

16

(a) Give unadjusted estimates and, if applicable, confounder-

Tables 1 & 2

adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included (b) Report category boundaries when continuous variables were

n/a

categorized (c) If relevant, consider translating estimates of relative risk into

n/a

absolute risk for a meaningful time period Other analyses

17

Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses

Pages 5-6 and Tables 1&2

Discussion Key results

18

Summarise key results with reference to study objectives

Lines 154-166

Limitations

19

Discuss limitations of the study, taking into account sources of

Lines 197-200

potential bias or imprecision. Discuss both direction and magnitude of any potential bias Interpretation

20

Give a cautious overall interpretation of results considering

Lines 202-208

objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence Generalisability

21

Discuss the generalisability (external validity) of the study results

Other information Funding

22

Give the source of funding and the role of the funders for the

Lines 168-187 Lines 222-5

present study and, if applicable, for the original study on which the present article is based *Give information separately for exposed and unexposed groups. Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at http://www.strobe-statement.org.

2

Inclusions N=3085

Exclusions

JoCoOA Project T1/T1* clinic participants (baseline, 1999-2004) No hand X-ray films read (n=1559)*

N=1526

JoCoOA Project T1/T1* clinic participants (1999-2004) with hand X-rays Did not participate at T3 (n=1071) • Lost to follow-up (n=616) • Deceased (n=455)

N=908

JoCoOA Project T3 clinic participants (follow up, 2013-2015) Missing complete x-ray information (n=109) • 83 missing x-rays • 25 missing specific joint scores

N=800

Available KL grades for all 30 hand joints at baseline and follow up

*Based on priority, hand x-rays for JoCo OA participants without follow-up have not yet been read.